BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL™ ...
> AutoGenomics, which makes molecular diagnostic machines, has withdrawn its regulatory filings for an initial public offering after a nearly three-year process, saying it chose not to offer itself on ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Results from a Cordis analysis presented at the 14 th Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) congress in Madrid indicates ...
Chicago, IL - A new vascular closure device with a bioabsorbable plug has shown impressive results in a pivotal multicenter trial, ECLIPSE. The device, named ExoSeal (Cordis), also has a unique ...
ISAR-CLOSURE: Vascular Closure Devices Noninferior to Manual Compression in Transfemoral Angiography
New data presented Saturday at TCT 2014 show that, in patients undergoing transfemoral coronary angiography, vascular closure devices match manual compression in terms of vascular access site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results